Discover best-in-market prices on clinically preferred products―together with a suite of applications supporting pharmacy operations and analytics, and innovative strategies to address industry initiatives and issues.

Battling Influenza With Leading-edge Vaccines

Influenza is one of the world’s most devastating vaccine-preventable diseases, which makes staying ahead of the disease with leading-edge immunology science even more crucial. “Though it’s hard to make projections on the upcoming flu season based on a prior season,” explains Dan DiVito, senior director influenza vaccines for Sanofi Pasteur U.S., “we look closely at […]

Read More

HealthTrust Honors Member Excellence in Five Categories

NASHVILLE, Tennessee—July 24, 2018—HealthTrust today recognized five member organizations with its highest honor, a Member Recognition Award, during the annual HealthTrust University Conference (HTU). The performance improvement company for healthcare established the Member Recognition program to acknowledge outstanding contributions of members and individuals for achieving operational excellence and demonstrating best practices benefitting healthcare providers and their […]

Read More

Care Across Distance

The Benefits & Potential Drawbacks of Telepharmacy Services When telepharmacy programs began in the early 2000s, the idea was simple: enable pharmacists to review prescription orders remotely. A physician prescribed a medication based on a patient’s needs and sent off orders to be reviewed by a pharmacist before a nurse administered the medication. In rural […]

Read More

Pharmaceutical Compounding

How to Meet Guidelines for Sterile Prep & Safe Handling of Hazardous Drugs The business of pharmaceutical compounding is becoming increasingly regulated. New standards from the United States Pharmacopeial Convention (USP)’s Chapter 800 (“Hazardous Drugs–Handling in Healthcare Settings) take effect in 2019. First, the USP released Chapter 795, which provides guidelines for non-sterile compounding, followed by […]

Read More

Hand of doctors holding many different pills

Under the Microscope

Antimicrobial Stewardship Goes Mainstream In July 2016, the Food and Drug Administration (FDA) issued a safety alert on the serious side effects associated with quinolones, a class of antibiotics that includes ciprofloxacin and levofloxacin. These drugs are convenient in many ways, notably because they treat a broad range of infections and are effective both intravenously […]

Read More

Under the Microscope

“The demand for trained pharmacy professionals has increased in past years,” according to the American Association of Colleges of Pharmacy (AACP), “due to the rapid growth of the healthcare and pharmaceutical industries, and the growing elderly population. The number of pharmacists in healthcare services is also growing, as pharmacists become more actively involved in drug […]

Read More

HealthTrust Presents 2017 Member Recognition Awards

LAS VEGAS, Nevada—July 18, 2017—HealthTrust has recognized 21 individuals with its highest honor during the 2017 HealthTrust University Conference in Las Vegas. The healthcare performance improvement company established its annual Member Recognition Award program to acknowledge outstanding contributions of member organizations for demonstrating best practices and achieving operational excellence benefitting providers and their patients. Awards […]

Read More

Pills and money

The 340B Drug Pricing Program

The 340B Drug Pricing Program requires drug manufacturers participating in Medicaid to provide outpatient drugs at significantly reduced prices to eligible healthcare organizations or covered entities, such as safety-net hospitals. This program was originally set up in 1992 to provide support to safety-net hospitals that take care of a large number of the poor and […]

Read More

Latest ICER Report Looks at the Value of Drugs for Rheumatoid Arthritis

Rheumatoid arthritis (RA) is the latest high-profile disease for which the Institute for Clinical and Economic Review (ICER) has constructed a “value framework” for assessing and comparing available drug treatments. In April, ICER issued a comprehensive, 529-page report on targeted immune modulators (TIMs) for RA that covers 14 medicines—all but two biologics, and none biosimilars. […]

Read More

Prioritizing Antimicrobial Stewardship

In 2014, California became the first state to require acute care hospitals to implement antimicrobial stewardship programs in their facilities. Nearly three years later, it remains the only state in the nation with such a law—but that is set to change. In June 2016, the Centers for Medicare & Medicaid Services (CMS) announced proposed changes […]

Read More

Pharmaceutical M&A: A New Kind of Drug Deal

As more drug companies merge and overtake each other, healthcare facilities and pharmaceutical customers are feeling the squeeze. With fewer companies in the marketplace, competition is limited, driving higher prices and drug scarcity.

Read More

Biosimilars Update: Zarxio

In March 2015, the FDA green-lighted Zarxio, the first biosimilar product to be approved in the United States, signaling some relief from rising drug costs.

Read More

HealthTrust Addressing Pharmacy Leadership Shortage With Unique Residency Program

In 2014, HealthTrust established the nation’s first corporate-based training program for future pharmacy leaders that provides early career exposure to critical business functions, value-based purchasing and the economic realities of modern medicine, including better management of limited healthcare resources.

Read More

Five Drivers of Rising Drug Costs

Supplier consolidation, heightened FDA scrutiny, industry profit-taking and recurring shortages are conspiring to inflate prices on older drugs.

Read More